ArticleNature biomedical engineering2021
Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.
Jung Seok Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.